Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT03280745

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03280745
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03280745. Randomized; quadruple masking; primary purpose prevention. Start 2018-02-27 (actual); primary completion 2019-05-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery
Acronym
HERACLES
Condition
Cardiovascular Diseases
Condition
Valvular Heart Disease
Intervention (Drug)
Hypertonic saline
Intervention (Drug)
0.9% saline
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)

Record details

Record id
cardio:ct-nct03280745
Content hash
00599ef01ba10b2837e0eb229683286a502ae154ca8f867f1e283858a3a2807c